Suppressive effect of Oren-gedoku-to (Huang-Lian-Jie-Du-Tang) on the production of superantigen by Staphylococcus aureus

Japanese Pharmacology and Therapeutics

Volumn 30, Issue 3, 2002, Pages 225-230

  Yoshimura Mishima, Miki ^a   Akamatsu, Hirohiko ^a   Adachi, Yukari ^a   Horio, Takeshi ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Oren gedoku to; Staphylococcus aureus; Superantigen (s)

Indexed keywords

BACTERIAL ANTIGEN; ORENGEDOKU TO; SUPERANTIGEN;

ADULT; ANTIBACTERIAL ACTIVITY; ANTIGEN EXPRESSION; ARTICLE; ATOPIC DERMATITIS; BACTERIAL GROWTH; BACTERIUM ISOLATION; CASE REPORT; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HERBAL MEDICINE; HUMAN; HUMAN CELL; HUMAN TISSUE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; REMISSION; SKIN DEFECT; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE ACTIVATION;

EID: 0036032111     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Cooper KD. Atopic dermatitis: Recent trends in pathogenesis and therapy?. J Invest Dermatol 1994; 102: 128-37.
2. Dahl MV. Staphylococcus aureus and atopic dermatitis?. Arch Dermatol 1983; 119: 840-6.
3. Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis?. Br J Dermatol 1974; 90: 525-30.
4. Hauser C,Wuethrich B, Matter L, Wilhelm JA, Sonnabend W, Schopfer K.Staphylococcus aureus skin colonization in atopic dermatitis patients?. Dermatologica 1985; 170: 35-9.
5. McFadden JP, Noble WC, Camp RD. Superantigenic exotoxin-secreting potential of staphylococci isolated from atopic eczematous skin. Br J Dermatol 1993; 128: 631-2.
6. Nilsson EJ, Henning CG, Magnusson J. Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. J Am Acad Dermatol 1992; 27: 29-34.
7. Leung DYM, et al. J Clin Invest 1995; 92: 1374-80.
8. Piemont Y, Rasoamananjara D, Fouace JM, Bruce T. Epidemiological investigation of exfoliative toxin-producing Staphylococcus aureus strains in hospitalized patients. J Clin Microbiol 1984; 19: 417-20.
9. Hoeger PH, Lenz W, Boutonnier A, Fournier JM. Staphylococcal skin colonization in children with atopic dermatitis: Prevalence, persistence, and transmission of toxigenic and nontoxigenic strains. J Infect Dis 1992; 165: 1064-8.
10. Chatila T, Geha RS. Signal transduction by microbial superantigens via MHC class II molecules. Immunol Rer 1993; 131: 43-59.
11. Wang LM, et al. J Med Pharm Soc WAKAN-YAKU 1993; 10: 73-5.
12. Wang LM, et al. J Med Pharm Soc WAKAN-YAKU 1994; 11: 390-1.
13. Mizukawa H, Yoshida K, Honmura A, Uchiyama Y, Kaku H, Nakajima S, et al. The effect of orengedokuto on experimentally-inflamed rats. Am J Chin Med 1993; 21: 71-8.
14. Hayakawa S, et al. Prog Med 1996; 16: 1703-6.
15. Baird-Parker AC. Bergeys Manual of Determinative Bacteriology, 8th Edn. Baltimore: Williams & Wilkins. 483-9.
16. Goto S, et al. Chemotherapy 1981; 29: 76-9.
17. Yoshimura M, Namura S, Akamatsu H, Horio T. Antimicrobial effects of phototherapy and photochemotherapy in vivo and in vitro. Br J Dermatol 1996; 135: 528-32.
18. Higaki S, et al. J Trad Med 1995; 12: 432-3.
19. Lin MT, Liu GG, Wu WL, Chern YF. Effects of Chinese herb, Huang Chin (Scutellaria baicalensis George) on thermoregulation in rats. Jpn J Pharmacol 1980; 30: 59-64.
20. Arakawa K, et al. J Med Pharm Soc WAKAN-YAKU 1985; 2: 317-29.
21. White J, Herman A, Pullen AM, Kubo R, Kappler JW, Marrack P. The V beta-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice. Cell 1989; 56: 27-35.
22. Rellahan BL, Jones LA, Kruisbeek AM, Fry AM, Matis LA. In vivo induction of anergy in peripheral V beta 8 + T cells by staphylococcal enterotoxin B. J Exp Med 1990; 172: 1091-100.
23. Carlsson R, Fischer H, Sjogren HO. Binding of staphylococcal enterotoxin A to accessory cells is a requirement for its ability to activate human T cells. J Immunol 1988; 140: 2484-8.
24. Dellabona P, Peccoud J, Kappler J, Marrack P, Benoist C, Mathis D. Superantigens interact with MHC class II molecules outside of the antigen groove. Cell 1990; 62: 1115-21.
25. Fleisher B, et al. J Immunol 1991; 146: 11-7.
26. Choi YW, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci USA 1989; 86: 8941-5.
27. Hewitt CR, Lamb JR, Hayball J, Hill M, Owen MJ, O'Hehir RE. Major histocompatibility complex independent clonal T cell anergy by direct interaction of Staphylococcus aureus enterotoxin B with the T cell antigen receptor. J Exp Med 1992; 175: 1493-7.
28. Jozefczyk Z. Specific human antibodies to enterotoxins A, B, and C1 of Staphylococcus: Their increased synthesis in staphylococcal infection. J Infect Dis 1974; 130: 1-7.
29. Solino Noleto AL, da Costa Cesar E, Bergdoll MS. Antibodies to staphylococcal enterotoxins and toxic shock syndrome toxin 1 in sera of patients and healthy people in Rio de Janeiro, Brazil. J Clin Microbiol 1986; 24: 809-11.
30. Lever R, Hadley K, Downey D, Mackie R. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol 1988; 119: 189-98.